Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| diazepam derivatives | 1936 | 2011-67-8 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 95 % |
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 2.123 | Moderate | 0.73 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.581 | Moderate | 0.73 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 89.743 | 10^-6 cm/s | Moderate | 0.73 |
| dh-clint | Dog hepatocyte intrinsic clearance | 38.459 | uL/min/10^6 cells | Moderate | 0.73 |
| dppb | Dog plasma protein binding (% unbound) | 21.670 | % | Moderate | 0.73 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 36.740 | % | Moderate | 0.73 |
| herg | hERG pIC50 | 4.547 | pIC50 | Moderate | 0.73 |
| hh-clint | Human hepatocyte intrinsic clearance | 4.887 | uL/min/10^6 cells | Moderate | 0.73 |
| hlm-clint | Human liver microsomal intrinsic clearance | 13.366 | uL/min/mg protein | Moderate | 0.73 |
| hppb | Human plasma protein binding (% unbound) | 21.400 | % | Moderate | 0.73 |
| kinase-safety-class | ACVR2B,AXL,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,ERBB2,GRK2,ITK,MAP3K1,MAP3K21,MAPK10,MAPK7,MARK4,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PRKDC,STK33,TEK,TTK | 25 | |||
| kinase-selectivity-class | AXL,GRK2,STK33,TTK | 4 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 1.340 | Moderate | 0.68 | |
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.681 | Moderate | 0.73 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 48.084 | Moderate | 0.73 | |
| mppb | Mouse plasma protein binding (% unbound) | 20.980 | Moderate | 0.73 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.822 | Moderate | 0.73 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 29.040 | % | Moderate | 0.73 |
| rat-kpuu-brain | Rat brain Kpuu | 0.200 | % | Moderate | 0.68 |
| rh-clint | Rat hepatocyte intrinsic clearance | 67.143 | uL/min/10^6 cells | Moderate | 0.73 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 82.720 | % | Moderate | 0.73 |
| rppb | Rat plasma protein binding (% unbound) | 20.560 | % | Moderate | 0.73 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 394.457 | uM | Moderate | 0.73 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | N05CD15 | NERVOUS SYSTEM PSYCHOLEPTICS HYPNOTICS AND SEDATIVES Benzodiazepine derivatives |
| MeSH PA | D000927 | Anticonvulsants |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D002492 | Central Nervous System Depressants |
| MeSH PA | D006993 | Hypnotics and Sedatives |
| MeSH PA | D011619 | Psychotropic Drugs |
| MeSH PA | D014149 | Tranquilizing Agents |
| MeSH PA | D014151 | Anti-Anxiety Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018682 | GABA Agents |
| MeSH PA | D018757 | GABA Modulators |
| CHEBI has role | CHEBI:35623 | anticonvulsant |
| CHEBI has role | CHEBI:35717 | sedative |
| CHEBI has role | CHEBI:50268 | GABA modulator |
| CHEBI has role | CHEBI:53784 | antispasmodic drug |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Insomnia | indication | 193462001 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.48 | Basic |
None
None
None
| ID | Source |
|---|---|
| D01593 | KEGG_DRUG |
| C0068774 | UMLSCUI |
| CHEBI:31912 | CHEBI |
| CHEMBL13341 | ChEMBL_ID |
| C002714 | MESH_SUPPLEMENTAL_RECORD_UI |
| 4496 | PUBCHEM_CID |
| 3150 | INN_ID |
| 4532264KW6 | UNII |
None